Subone and behavioural therapy is a combined outpatient drug detox progam for painkiller and other opiate addictions. Chemical substance addiction is a complex disorder. Therefore recovery is a combination of pharmacology (Suboxone) and behavioural therapy.
Suboxone detox is not a treatment by itself.
The primary purpose is to alleviate the uncomfortable effects of withdrawal and cravings to opiates while the patient is relearning how to live without opiates. Suboxone helps avoid typical withdrawal symptoms, such as diarrhea, cold sweats, anxiety, aches, goose bumps and insomnia. After the initial treatment phase, recommended follow up is an after-care program in the form of abstinence or long-term maintenance using Suboxone or methadone along with psychotherapy.
To prevent relapse, education and counseling are integral parts of the recovery equation. A comprehensive education program should encompass the most current information including substance abuse and addiction risk factors, predisposing conditions, treatment procedures and an exit strategy.
For most clients, both individual and group counseling (as well as participation in self-help programs) are essential components of our comprehensive treatment programs.
What is Suboxone?
Suboxone (or “Buprenorphine” or “Subutex”) is an FDA-approved medication for office-based treatment of opiate addiction. When deemed appropriate by your physician, a Suboxone treatment can provide a more comfortable recovery. Suboxone treatments generally enable patients to recover from an opiate dependence without being confined to a hospital or a drug rehab center.
Common side effects might include headaches, sleep disorders, constipation and sweating. Comparable to methadone, studies found that Suboxone has a high safety profile. In certain situations, severe breathing interruptions can occur (as with any opiate). Suboxone should be avoided in patients who are allergic to opioids. In addition it should not be taken in combination with other opiates, alcohol, benzodiazepines or other CNS depressants.
We provide state-of-the-art suboxone treatment centers.
ATTC – Addiction Technology Transfer Center is a network that partners with SAMHSA and other authorities to evaluate the effectiveness of Suboxone within special populations, such as effects on teenagers, pregnant women, and prescription pain killer additions. Their primary objectives are to raise awareness about addiction treatments and recovery services, build workforce skills and change habits to improve addiction treatment and recovery outcomes. Learn more about ATTC.
NIDA – National Institute on Drug Abuse
NIDA conducts scientific research across a broad range of disciplines on drug abuse and addictions and provideses these results to educate the public. Their underlying goal is to improve prevention, treatment and policy in relation to drug abuse and addictions. Learn more about NIDA
SAMHSA – Substance Abuse and Mental Health Service Administration
SAMHSA works to improve the quality and availability of substance abuse prevention, alcohol and drug addiction treatment and mental health services